Share-based Payment Arrangement, Expense of INTENSITY THERAPEUTICS, INC. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
INTENSITY THERAPEUTICS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • INTENSITY THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $471,000, a 2.5% decline year-over-year.
  • INTENSITY THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2,394,000, a 9.7% decline year-over-year.
  • INTENSITY THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $3,073,000, a 120% increase from 2023.
  • INTENSITY THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $1,398,000, a 20% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

INTENSITY THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,394,000 $471,000 -$12,000 -2.5% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $2,406,000 $644,000 +$53,000 +9% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $2,353,000 $435,000 -$720,000 -62% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $3,073,000 $844,000 +$421,000 +100% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $2,652,000 $483,000 +$132,000 +38% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $2,520,000 $591,000 +$279,000 +89% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $2,241,000 $1,155,000 +$843,000 +270% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $1,398,000 $423,000 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $351,000 +$314,000 +849% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $312,000 +$116,000 +59% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $312,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $37,000 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $196,000 01 Apr 2022 30 Jun 2022 10-Q/A 14 Aug 2023 2023 Q2

INTENSITY THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,073,000 +$1,675,000 +120% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $1,398,000 +$229,000 +20% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $1,169,000 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.